Medline continues to invest in the resiliency of the supply chain through its national capital expenditure campaign, the Healthcare Resilience Initiative. Since 2018, the company has invested $2 billion in its U.S. distribution centers, manufacturing capabilities and IT upgrades to further its commitment to delivering superior customer service, with an additional $400M planned for 2022.
“Medline has implemented significant infrastructure expansions to ensure the resiliency of the healthcare supply chain and to help providers activate the clinical and supply chain resources needed to deliver their best care,” said Jim Boyle, executive vice president for Medline. “As the operators of the largest U.S. supply chain of any medical-surgical manufacturer and distributor, we continue to explore new solutions for the supply chain challenges our industry faces today while also preparing for tomorrow.”
Throughout the pandemic, Medline has focused on implementing new ideas to address the significant increase in demand for medical supplies nationwide, including expanding its U.S. manufacturing capabilities. The company’s latest North American manufacturing expansion is the addition of Micro-Kill disinfectant wipes to its Hartland, Wisconsin facility operations, with production beginning in the fourth quarter of 2022.
Learn how Medline tailors solutions across the entire continuum of care as a manufacturer and distributor.